11.39 USD
↘ 0.04 (0.35%)AT CLOSE (11:59 AM EDT)
Olema Pharmaceuticals, Inc. Common Stock
OLMANASDAQ • USD
11.03
↘ 0.36 (3.20%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
11.03
↘ 0.36 (3.20%)
Market: CLOSED
Shares of Olema Pharmaceuticals, Inc. Common Stock (OLMA) are trading at $11.39. Technicals currently rate "Neutral" while our fundamental analysis reads "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, OLMA appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jun 26, 2026.
Open?$11.43
High?$11.75
Low?$11.08
Prev. Close?$11.43
Volume?5.5M
Avg. Volume?1.7M
VWAP?$11.37
Rel. Volume?3.19x
Bid / Ask
Bid?$9.81 × 100
Ask?$13.40 × 100
Spread?$3.59
Midpoint?$11.61
Valuation & Ratios
Market Cap?994.9M
Shares Out?87.3M
Float?57.7M
Float %?66.1%
P/E Ratio?N/A
P/B Ratio?2.07
EPS?-$2.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Address
780 BRANNAN STREET
SAN FRANCISCO, CA 94103
Phone: (415) 651-3316
SAN FRANCISCO, CA 94103
Phone: (415) 651-3316
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?23
Short Sent.?40
Piotroski F-Score?0/9Weak
Altman Z-Score?9.98Safe
Confidence?45%Low
Short InterestSqueeze Risk
Short % of Float?22.25%Squeeze Risk
Short Interest?12.8M
Days to Cover?7.9
Free Float57.7M
Avg Daily Volume1.6M
Settlement Date2026-06-15
Financial Health
Current Ratio?10.88Strong
Quick Ratio?10.88Strong
Cash Ratio?1.11Strong
Debt/Equity?0.01Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.07CHEAP▾
Peers100
S&P73
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-4.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-38.5%WEAK▾
S&P3
ROA?-34.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$945.3M
Fundamentals ratios updated end of day